Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.